We are live on ! Find out more
THRD

Third Harmonic Bio

Delisted

THRD was delisted on the 30th of July, 2025.

84 hedge funds and large institutions have $597M invested in Third Harmonic Bio in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 18

14% more capital invested

Capital invested by funds: $523M → $597M (+$73.4M)

11% more funds holding

Funds holding: 7684 (+8)

8.85% more ownership

Funds ownership: 98.28%107.12% (+8.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
84
Holders Change
+8
Holders Change %
+10.53%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
14
Increased
36
Reduced
18
Closed
6
Calls
$96K
Puts
Net Calls
+$96K
Net Calls Change
-$22K

THRD Hedge Fund Activity: Q3 2024 in Review

84 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q3 2024, worth a combined $597M — up 14% from $523M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new THRD positions and 6 closed out — a net gain of 8 holders — while 36 added to existing stakes and 18 trimmed.

The largest buyer was TCG Crossover Management, opening a new position worth an estimated $29.9M. The largest seller was RA Capital Management, cutting an estimated $9.32M.

  • 84 institutional investors held Third Harmonic Bio (THRD) as of Q3 2024, up from 76 in Q2 2024.
  • Funds reported $597M of Third Harmonic Bio stock for Q3 2024, up 14% quarter-over-quarter.
  • 14 funds opened new Third Harmonic Bio positions in Q3 2024 and 6 closed out, a net change of +8 holders.
  • The largest Third Harmonic Bio buyer in Q3 2024 was TCG Crossover Management, an estimated $29.9M added.
  • The largest Third Harmonic Bio seller in Q3 2024 was RA Capital Management, an estimated $9.32M sold.

Based on aggregated 13F filings for Q3 2024.